[1] |
CHITTY L S,KAGAN K O,MOLINA F S,et al.Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening:observational study[J]. BMJ,2006,332(7539):452-455.
|
[2] |
NICOLAIDES K H,SEBIRE N J,SNIJDERS R J.Down's syndrome screening in the UK[J]. Lancet,1996,347(9005):906-907.
|
[3] |
HAFNER E,SCHUCHTER K,LIEBHART E,et al.Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4 233 unselected pregnant women[J]. Prenat Diagn,1998,18(1):29-34.
|
[4] |
ZALEL Y,ZEMET R,KIVILEVITCH Z.The added value of detailed early anomaly scan in fetuses with increased nuchal translucency[J]. Prenat Diagn,2017,37(3):235-243.
|
[5] |
BATZIR N A,SHOHAT M,MAYA I.Chromosomal microarray analysis(CMA) a clinical diagnostic tool in the prenatal and postnatal settings[J]. Pediatr Endocrinol Rev,2015,13(1):448-454.
|
[6] |
GRANDE M,JANSEN F A,BLUMENFELD Y J,et al.Genomic microarray in fetuses with increased nuchal translucency and normal karyotype:a systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol,2015,46(6):650-658.
|
[7] |
DONAGHE C,MANN K,DIACK J S W,et al. ACC/CMGS best practice guidelines for QF-PCR-based diagnosis of aneuploid [Z]. 2004.
|
[8] |
KEARNEY H M,THORLAND E C,BROWN K K,et al.American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants[J]. Genet Med,2011,13(7):680-685.
|
[9] |
BILARDO C M,MÜLLER M A,PAJKRT E,et al. Increased nuchal translucency thickness and normal karyotype:time for parental reassurance[J]. Ultrasound Obstet Gynecol,2007,30(1):11-18.
|
[10] |
KAGAN K O,AVGIDOU K,MOLINA F S,et al.Relation between increased fetal nuchal translucency thickness and chromosomal defects[J]. Obstet Gynecol,2006,107(1):6-10.
|
[11] |
YANG X,LI R,FU F,et al.Submicroscopic chromosomal abnormalities in fetuses with increased nuchal translucency and normal karyotype[J]. J Matern Fetal Neonatal Med,2016,30(2):194-198.
|
[12] |
董媛,司艳梅,张萌,等. 胎儿NT厚度与染色体异常的关系探讨[J]. 中国优生与遗传杂志,2017,25(3):53-55.
|
[13] |
ALI M M,CHASEN S T,NORTON M E .Testing for Noonan syndrome after increased nuchal translucency[J]. Prenat Diagn,2017,37(8):750-753.
|
[14] |
BORNSTEIN E,BERGER S,CHEUNG S W,et al.Universal prenatal chromosomal microarray analysis:additive value and clinical dilemmas in fetuses with a normal karyotype[J]. Am J Perinatol,2017,34(4):340-348.
|
[15] |
HILLMAN S C,MCMULLAN D J,HALL G,et al.Use of prenatal chromosomal microarray:prospective cohort study and systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol,2013,41(6):610-620.
|
[16] |
BOGGULA V R,AGARWAL M,KUMAR R,et al.Recurrent benign copy number variants and issues in interpretation of variants of unknown significance identified by cytogenetic microarray in Indian patients with intellectual disability[J]. Indian J Med Res,2015,142(6):699-712.
|
[17] |
杜满兴,王伟佳,苏年华,等. 2 018例孕中期胎儿染色体核型分析结果回顾性分析[J]. 检验医学,2016,31(9):778-781.
|
[18] |
ANTONARAKIS S E,LYLE R,DERMITZAKIS E T,et al.Chromosome 21 and down syndrome:from genomics to pathophysiology[J]. Nat Rev Genet,2004,5(10):725-738.
|